Corvus Pharmaceuticals, Inc.CRVSNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+4.5%/yr
vs -6.6%/yr prior
5Y CAGR
-5.0%/yr
Recent acceleration
Acceleration
+11.1pp
Accelerating
Percentile
P55
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.25M | +13.3% |
| 2024 | $8.16M | +18.6% |
| 2023 | $6.88M | -15.0% |
| 2022 | $8.10M | -14.9% |
| 2021 | $9.52M | -20.2% |
| 2020 | $11.93M | +9.7% |
| 2019 | $10.88M | +2.3% |
| 2018 | $10.64M | +4.1% |
| 2017 | $10.22M | +34.1% |
| 2016 | $7.62M | - |